ASH · Ashland Inc.
Price & Indicators
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | $265M | Nine months ended June 30, 2026 | — |
|
|
|||
| Adjusted Income from Continuing Operations Excluding Intangibles Amortization Expense non-GAAP | $101M | Nine months ended June 30, 2026 | — |
|
|
|||
| Adjusted Operating Income non-GAAP | $131M | Nine months ended June 30, 2026 | — |
| Adjusted unallocated and other expense EBITDA non-GAAP | $20M | the third quarter | — |
| Cash (inflows) outflows from U.S. Accounts Receivable Sales Program non-GAAP | -$9M | Nine months ended June 30, 2026 | — |
| Cash inflows from Foreign Accounts Receivable Sales Program non-GAAP | -$12M | Nine months ended June 30, 2026 | — |
| Environmental and related litigation payments non-GAAP | $21M | Nine months ended June 30, 2026 | — |
| Free Cash Flows non-GAAP | $244M | Nine months ended June 30, 2026 | — |
| Ongoing Free Cash Flow non-GAAP | $159M | Nine months ended June 30, 2026 | — |
|
|
|||
| Ongoing Free Cash Flow Conversion non-GAAP | 60% | Nine months ended June 30, 2026 | — |
| Operating Cash Flow Conversion non-GAAP | 1,475% | Nine months ended June 30, 2026 | — |
| Restructuring-related payments non-GAAP | $18M | Nine months ended June 30, 2026 | — |
| Adjusted EBITDA margin non-GAAP | 15% | first quarter of fiscal year 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Specialty Chemicals — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
ASH
this stock
Ashland Inc.
|
$3.33B | +23.8% | -13.7% | — | 9.8% |
|
LIN
Linde PLC
|
$224.76B | +14.3% | +3.0% | 31.5 | 1.2% |
|
AIQUF
L Air Liquide SA /Fi
|
$124.60B | +4.3% | — | — | 0.0% |
|
SHW
Sherwin Williams Co
|
$84.14B | +7.0% | +2.1% | 32.0 | 2.6% |
|
ECL
Ecolab Inc.
|
$78.95B | +7.3% | +2.2% | 37.8 | 1.1% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| ASH | -1.4% | +9.4% | +18.8% | +0.1% | +23.9% |
| SPY | -1.4% | +3.6% | +11.6% | +2.5% | +12.3% |
| vs SPY | -0.1% | +5.8% | +7.3% | -2.4% | +11.6% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.